🇺🇸 glargine basal insulin and glulisine prandial insulin in United States

glargine basal insulin and glulisine prandial insulin (glargine basal insulin and glulisine prandial insulin) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

glargine basal insulin and glulisine prandial insulin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is glargine basal insulin and glulisine prandial insulin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for glargine basal insulin and glulisine prandial insulin in United States?

Emory University is the originator. The local marketing authorisation holder may differ — check the official source linked above.